Astrazeneca Phar

{
  "main_header": {
    "sid": 777011,
    "name": "Astrazeneca Phar",
    "stock_name": "Astrazeneca Phar",
    "full_name": "Astrazeneca Pharma India Ltd",
    "name_url": "stocks-analysis/astrazeneca-phar",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "8,610.95",
    "chg": -76.65,
    "chgp": "-0.88%",
    "dir": -1,
    "prev_price": "8,687.60",
    "mcapval": "21,919.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 506820,
    "symbol": "ASTRAZEN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE203A01020",
    "curr_date": "May 20",
    "curr_time": "",
    "bse_nse_vol": "7.1 k",
    "exc_status": "Active",
    "traded_date": "May 20, 2026",
    "traded_date_str": "2026 05 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/astrazeneca-phar-777011-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Astrazeneca Pharma India Ltd Technical Momentum Shifts Amid Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-technical-momentum-shifts-amid-mixed-signals-4000175",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstrazenecaPhar_technicaldot_4000175.png",
        "date": "2026-05-20 08:03:33",
        "description": "Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a 2.19% gain on 20 May 2026, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term trajectory."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-3995354",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstrazenecaPhar_mojoScore_3995354.png",
        "date": "2026-05-17 10:10:15",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 May 2026, providing investors with an up-to-date view of its performance and outlook."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-sees-mixed-technical-signals-amid-mild-momentum-shift-3980765",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstrazenecaPhar_technicaldot_3980765.png",
        "date": "2026-05-08 08:03:49",
        "description": "Astrazeneca Pharma India Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent upgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical indicators suggest a cautiously evolving outlook for this small-cap pharmaceutical player."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-3977648",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstrazenecaPhar_mojoScore_3977648.png",
        "date": "2026-05-06 10:10:03",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO. This rating was last updated on 02 Jan 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3973648",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstrazenecaPhar_technicaldot_3973648.png",
        "date": "2026-05-04 08:01:42",
        "description": "Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, moving from a bearish to a mildly bearish trend as of early 2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s mixed technical signals across key indicators such as MACD, RSI, Bollinger Bands, and moving averages suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-faces-bearish-momentum-amid-technical-downgrade-3967484",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstrazenecaPhar_technicaldot_3967484.png",
        "date": "2026-04-29 08:02:41",
        "description": "Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite some bullish signals on longer-term indicators, the overall technical landscape suggests caution for investors as the stock contends with downward pressure amid mixed momentum indicators and a recent downgrade in its Mojo Grade to Sell."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-3962181",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstrazenecaPhar_mojoScore_3962181.png",
        "date": "2026-04-25 10:10:14",
        "description": "Astrazeneca Pharma India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3946666",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstrazenecaPhar_technicaldot_3946666.png",
        "date": "2026-04-15 08:03:27",
        "description": "Astrazeneca Pharma India Ltd has experienced a notable shift in price momentum, reflected in a 5.21% gain on 15 Apr 2026, as technical indicators reveal a complex picture of mildly bearish to bullish signals across weekly and monthly timeframes. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s long-term returns remain robust, outperforming the Sensex over multiple periods."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-3945626",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstrazenecaPhar_mojoScore_3945626.png",
        "date": "2026-04-14 10:10:14",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO. This rating was last updated on 02 Jan 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 14 April 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 365,
    "sid": "777011",
    "stock_news_url": "https://www.marketsmojo.com/news/astrazeneca-pharma-india-777011"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association",
      "datetime": "12-May-2026",
      "details": "Please find the enclosed intimation of the Company as per the captioned subject for your reference.",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "12-May-2026",
      "details": "Please find the enclosed intimation of the Company as per the captioned subject for your reference.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association",
      "datetime": "12-May-2026",
      "details": "This is in reference to the intimation submitted to the exchange at 1:05 PM under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 regarding the amendment to the 2nd Clause of the Companys Memorandum of Association. Please note that the date of declaration of results was inadvertently stated as May 11 2026 instead of the correct date May 12 2026. Accordingly please find the revised intimation for your reference and records.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Astrazeneca Pharma India Ltd has declared <strong>1600%</strong> dividend, ex-date: 18 Jul 25",
          "dt": "2025-07-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Astrazeneca Pharma India Ltd has announced <strong>2:10</strong> stock split, ex-date: 15 Jun 06",
          "dt": "2006-06-15",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Astrazeneca Pharma India Ltd Technical Momentum Shifts Amid Mixed Signals

2026-05-20 08:03:33

Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a 2.19% gain on 20 May 2026, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term trajectory.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-05-17 10:10:15

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 May 2026, providing investors with an up-to-date view of its performance and outlook.

Read full news article

Astrazeneca Pharma India Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift

2026-05-08 08:03:49

Astrazeneca Pharma India Ltd has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent upgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical indicators suggest a cautiously evolving outlook for this small-cap pharmaceutical player.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-05-06 10:10:03

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO. This rating was last updated on 02 Jan 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 06 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Astrazeneca Pharma India Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-05-04 08:01:42

Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, moving from a bearish to a mildly bearish trend as of early 2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s mixed technical signals across key indicators such as MACD, RSI, Bollinger Bands, and moving averages suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Astrazeneca Pharma India Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-04-29 08:02:41

Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. Despite some bullish signals on longer-term indicators, the overall technical landscape suggests caution for investors as the stock contends with downward pressure amid mixed momentum indicators and a recent downgrade in its Mojo Grade to Sell.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-04-25 10:10:14

Astrazeneca Pharma India Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Astrazeneca Pharma India Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-04-15 08:03:27

Astrazeneca Pharma India Ltd has experienced a notable shift in price momentum, reflected in a 5.21% gain on 15 Apr 2026, as technical indicators reveal a complex picture of mildly bearish to bullish signals across weekly and monthly timeframes. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s long-term returns remain robust, outperforming the Sensex over multiple periods.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-04-14 10:10:14

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO. This rating was last updated on 02 Jan 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 14 April 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News